Onco Therapy Science Cancer Drugs Clinical Pipeline Insight

Publish Date:- Nov-2016       No Of Pages (52)

Electronic Access - Single User License $600 Buy Now
CD-ROM Mail Delivery $900Buy Now
Hard Copy Mail Delivery $900 Buy Now
Electronic Access - Multi-User License $1200 Buy Now


“Onco Therapy Science - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Onco Therapy Science. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “16” cancer drugs in clinical pipeline and majority of them are in preclinical phase.

The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of Action, Granted Orphan Designation, Fast Track Development Status, Clinical Introduction, Drug Formulation/ Route, Owner/License, Multiple Development Phase of particular drug and Patent Information.

“Onco Therapy Science - Cancer Drugs Clinical Pipeline Insight” report is comprehensively researched and well drafted encyclopedia which helps to analyze and understand the various parameters involved in the clinical development of cancer drugs by the respective company. This research publication also helps in identifying the long term investment and partnering opportunity for the various stake holders of the pharmaceutical industry.


“Onco Therapy Science - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Onco Therapy Science. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “16” cancer drugs in clinical pipeline and majority of them are in preclinical phase.

The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of Action, Granted Orphan Designation, Fast Track Development Status, Clinical Introduction, Drug Formulation/ Route, Owner/License, Multiple Development Phase of particular drug and Patent Information.

“Onco Therapy Science - Cancer Drugs Clinical Pipeline Insight” report is comprehensively researched and well drafted encyclopedia which helps to analyze and understand the various parameters involved in the clinical development of cancer drugs by the respective company. This research publication also helps in identifying the long term investment and partnering opportunity for the various stake holders of the pharmaceutical industry.

1. Onco Therapy Science

  1.1 Business Overview

  1.2 Onco Therapy Science Cancer Pipeline Overview

 

2. Onco Therapy Science Cancer Drugs in Research Phase

  2.1 Cancer Vaccines - Fukushima Medical University/OncoTherapy

  2.2 kinase inhibitors - OncoTherapy Science/Carna Biosciences/CrystalGenomics

 

3. Onco Therapy Science Cancer Drugs in Preclincal Phase

  3.1 OTS 167

  3.2 Small Molecule Enzyme Inhibitors - OncoTherapy Science

  3.3 Cancer Therapy - OncoTherapy/Shionogi

  3.4 Anticancer Antibodies - OncoTherapy Science/MBL

  3.5 Anticancer Therapeutics - OncoTherapy Science/Nimura Genetic Solutions

  3.6 Cancer Vaccines - OncoTherapy Science/Otsuka Pharmaceuticals

 

4. Onco Therapy Science Cancer Drugs in Phase-I

  4.1 ONO 7268MX1

  4.2 Yttrium 90-Radiolabelled OTSA 101

  4.3 ONO 7268MX2

  4.4 OCV C02

 

5. Onco Therapy Science Cancer Drugs in Phase-I/II

  5.1 S 488210

 

6. Onco Therapy Science Cancer Drugs in Phase-II

  6.1 OCV 101

  6.2 Gastric Cancer Vaccine - OncoTherapy Science

 

7. Onco Therapy Science Cancer Drugs in Phase-III

  7.1 S 288310/S 488310

 

 8. No Development Reported in Cancer Drug in Clinical Pipeline

  8.1 Elpamotide

 

9. Discontinued in Cancer Drug in Clinical Pipeline

  9.1 OCV C01

  9.2 S 488410

  9.3 S S 288310

  9.4 OCV 105

  9.5 NCV 01

  9.6 S 488310

  9.7 Lung Cancer Therapeutics - OncoTherapy Science/Yakult Honsha

  9.8 Anticancer Therapeutics - BioWa/OncoTherapy Science

  9.9 Lung Cancer Therapeutics - Sankyo


Figure 1-1: Onco Therapy Science Cancer Pipeline by Phase (%)

Figure 1-2: Onco Therapy Science Cancer Pipeline by Phase (Number)

Figure 1-3: Onco Therapy Science Cancer Drugs Discontinued & No Development Reported in Clinical Pipeline by Phase (%)

Figure 1-4: Onco Therapy Science Cancer Drugs Discontinued & No Development Reported in Clinical Pipeline by Phase (Number)